BTIM — Million Health Technology Income Statement
0.000.00%
TechnologyHighly SpeculativeMicro Cap
- $0.01m
- $2.27m
- $0.00m
Annual income statement for Million Health Technology, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2017 August 31st | 2018 August 31st | 2019 August 31st | 2020 August 31st | 2021 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.083 | 0 | 0 | 0 | 0.001 |
Cost of Revenue | |||||
Gross Profit | 0.008 | — | — | 0 | 0.001 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.119 | 0.078 | 0.156 | 0.68 | 2.32 |
Operating Profit | -0.036 | -0.078 | -0.156 | -0.68 | -2.32 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.036 | -0.078 | -0.156 | -0.41 | -3.12 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.036 | -0.078 | -0.156 | -0.41 | -3.12 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.036 | -0.078 | -0.156 | -0.41 | -3.12 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.036 | -0.078 | -0.156 | -0.41 | -3.12 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.001 | -0.002 | -0.002 | -0.008 | -0.06 |
Dividends per Share |